107 related articles for article (PubMed ID: 17185207)
1. Costs and cost-effectiveness of adolescent compliance with treatment for latent tuberculosis infection: results from a randomized trial.
Kominski GF; Varon SF; Morisky DE; Malotte CK; Ebin VJ; Coly A; Chiao C
J Adolesc Health; 2007 Jan; 40(1):61-8. PubMed ID: 17185207
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of isoniazid chemoprevention in close contacts.
Diel R; Nienhaus A; Schaberg T
Eur Respir J; 2005 Sep; 26(3):465-73. PubMed ID: 16135730
[TBL] [Abstract][Full Text] [Related]
3. Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre.
Aisu T; Raviglione MC; van Praag E; Eriki P; Narain JP; Barugahare L; Tembo G; McFarland D; Engwau FA
AIDS; 1995 Mar; 9(3):267-73. PubMed ID: 7755915
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of including tuberculin skin testing in an IPT program for HIV-infected persons in Uganda.
Shrestha RK; Mugisha B; Bunnell R; Mermin J; Hitimana-Lukanika C; Odeke R; Madra P; Adatu F; Blandford JM
Int J Tuberc Lung Dis; 2006 Jun; 10(6):656-62. PubMed ID: 16776453
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and cost effectiveness of early and late prevention of HIV/AIDS progression with antiretrovirals or antibiotics in Southern African adults.
Bachmann MO
AIDS Care; 2006 Feb; 18(2):109-20. PubMed ID: 16338768
[TBL] [Abstract][Full Text] [Related]
6. Predicting completion of treatment among foreign-born adolescents treated for latent tuberculosis infection in Los Angeles.
Coly A; Morisky D
Int J Tuberc Lung Dis; 2004 Jun; 8(6):703-10. PubMed ID: 15182139
[TBL] [Abstract][Full Text] [Related]
7. Cost-utility of tuberculosis prevention among HIV-infected adults in Kampala, Uganda.
Shrestha RK; Mugisha B; Bunnell R; Mermin J; Odeke R; Madra P; Hitimana-Lukanika C; Adatu-Engwau F; Blandford JM
Int J Tuberc Lung Dis; 2007 Jul; 11(7):747-54. PubMed ID: 17609049
[TBL] [Abstract][Full Text] [Related]
8. A cost--utility analysis of treatment options for inguinal hernia in 1,513,008 adult patients.
Stylopoulos N; Gazelle GS; Rattner DW
Surg Endosc; 2003 Feb; 17(2):180-9. PubMed ID: 12415334
[TBL] [Abstract][Full Text] [Related]
9. Isoniazid preventive therapy programmes for healthcare workers in India: translating evidence into policy.
Raj R; Prasad H; Arya BK; Bhattacharya SD
Natl Med J India; 2011; 24(4):201-7. PubMed ID: 22208138
[TBL] [Abstract][Full Text] [Related]
10. Modelling the cost-effectiveness of strategies to prevent tuberculosis in child contacts in a high-burden setting.
Mandalakas AM; Hesseling AC; Gie RP; Schaaf HS; Marais BJ; Sinanovic E
Thorax; 2013 Mar; 68(3):247-55. PubMed ID: 22717944
[TBL] [Abstract][Full Text] [Related]
11. Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a cost-effectiveness analysis based on a multicenter clinical trial.
Jasmer RM; Snyder DC; Saukkonen JJ; Hopewell PC; Bernardo J; King MD; Kawamura LM; Daley CL;
Clin Infect Dis; 2004 Feb; 38(3):363-9. PubMed ID: 14727206
[TBL] [Abstract][Full Text] [Related]
12. Incremental cost-effectiveness of a collaborative care intervention for panic disorder.
Katon W; Russo J; Sherbourne C; Stein MB; Craske M; Fan MY; Roy-Byrne P
Psychol Med; 2006 Mar; 36(3):353-63. PubMed ID: 16403243
[TBL] [Abstract][Full Text] [Related]
13. Behavioral interventions for the control of tuberculosis among adolescents.
Morisky DE; Malotte CK; Ebin V; Davidson P; Cabrera D; Trout PT; Coly A
Public Health Rep; 2001; 116(6):568-74. PubMed ID: 12196616
[TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness of treating multi-drug resistant tuberculosis by adding Deltyba™ to background regimens in Germany.
Diel R; Hittel N; Schaberg T
Respir Med; 2015 May; 109(5):632-41. PubMed ID: 25862597
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of tuberculosis screening and isoniazid treatment in the TB/HIV in Rio (THRio) Study.
Azadi M; Bishai DM; Dowdy DW; Moulton LH; Cavalcante S; Saraceni V; Pacheco AG; Cohn S; Chaisson RE; Durovni B; Golub JE
Int J Tuberc Lung Dis; 2014 Dec; 18(12):1443-8. PubMed ID: 25517809
[TBL] [Abstract][Full Text] [Related]
16. The effect of financial incentives on adherence with outpatient human immunodeficiency virus testing referrals from the emergency department.
Haukoos JS; Witt MD; Coil CJ; Lewis RJ
Acad Emerg Med; 2005 Jul; 12(7):617-21. PubMed ID: 15995093
[TBL] [Abstract][Full Text] [Related]
17. The cost of intensified case finding and isoniazid preventive therapy for HIV-infected patients in Battambang, Cambodia.
Sutton BS; Arias MS; Chheng P; Eang MT; Kimerling ME
Int J Tuberc Lung Dis; 2009 Jun; 13(6):713-8. PubMed ID: 19460246
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy.
Sanders GD; Bayoumi AM; Sundaram V; Bilir SP; Neukermans CP; Rydzak CE; Douglass LR; Lazzeroni LC; Holodniy M; Owens DK
N Engl J Med; 2005 Feb; 352(6):570-85. PubMed ID: 15703422
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of alternative treatments for depression in low-income women.
Beil H; Beeber LS; Schwartz TA; Lewis G
J Ment Health Policy Econ; 2013 Jun; 16(2):55-65. PubMed ID: 23999203
[TBL] [Abstract][Full Text] [Related]
20. A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users.
Chaisson RE; Barnes GL; Hackman J; Watkinson L; Kimbrough L; Metha S; Cavalcante S; Moore RD
Am J Med; 2001 Jun; 110(8):610-5. PubMed ID: 11382368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
